Neurocrine's market cap is currently ―. The company's EPS TTM is $2.43; its P/E ratio is 57.17; Neurocrine is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $1.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 515.20M	$ 498.80M	$ 452.70M	$ 420.40M	$ 412.00M
Gross Profit	$ 506.70M	$ 487.60M	$ 441.20M	$ 411.90M	$ 404.30M
EBIT	$ 199.30M	$ 116.70M	$ 122.90M	$ -102.20M	$ 110.60M
EBITDA	$ 186.80M	$ 122.40M	$ 128.20M	$ -97.00M	$ 115.20M
Net Income Common Stockholders	$ 147.70M	$ 83.10M	$ 95.50M	$ -76.60M	$ 89.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.03B	$ 1.10B	$ 976.70M	$ 894.60M	$ 989.30M
Total Assets	$ 3.25B	$ 2.85B	$ 2.61B	$ 2.36B	$ 2.37B
Total Debt	$ 428.40M	$ 255.80M	$ 258.80M	$ 259.90M	$ 262.90M
Net Debt	$ -603.20M	$ -839.30M	$ -717.90M	$ -634.70M	$ -726.40M
Total Liabilities	$ 1.02B	$ 846.10M	$ 760.10M	$ 675.30M	$ 2.37B
Stockholders Equity	$ 2.23B	$ 2.00B	$ 1.85B	$ 1.68B	$ 1.71B
Cash Flow	-
Free Cash Flow	$ 118.10M	$ 204.40M	$ 172.80M	$ -133.70M	$ 141.20M
Operating Cash Flow	$ 123.50M	$ 212.00M	$ 179.60M	$ -125.20M	$ 143.00M
Investing Cash Flow	$ -201.80M	$ -97.30M	$ -125.90M	$ -42.10M	$ -115.60M
Financing Cash Flow	$ 35.40M	$ 18.80M	$ 2.90M	$ 8.20M	$ 24.60M

Currency in USD

Neurocrine Earnings and Revenue History

Income Statement >

Neurocrine Debt to Assets

Balance Sheet >

Neurocrine Cash Flow

Cash Flow >

Neurocrine Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing